Differential cell sensitivity between OTA and LPS upon releasing TNF-α

Toxins

Volumn 2, Issue 6, 2010, Pages 1279-1299

  Al Anati, Lauy ^a,b   Essid, Ebtisam ^a   Stenius, Ulla ^b   Beuerlein, Knut ^c   Schuh, Klaus ^a   Petzinger, Ernst ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

HepG2 cells; Kupffer cells; Lipopolysaccharide; Macrophages; Ochratoxin A; Rat hepatocytes; Rat liver sinusoidal endothelial cells; Tumor necrosis factor

Indexed keywords

CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; OCHRATOXIN; RAF PROTEIN; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL STRAIN HEPG2; CELL STRAIN L 929; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RESPONSE; CYTOTOXICITY TEST; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN CELL; KUPFFER CELL; LIVER SINUSOID; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; DRUG INTERACTIONS; ENDOTHELIAL CELLS; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; OCHRATOXINS; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 79952090496     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins2061279     Document Type: Article

References (50)

1. Joint FAO/WHO. Safety evaluation of certain mycotoxins in food. Prepared by the 56th Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). WHO Food Additives Series L: 46. Ochratoxin A. International Programme on Food Safety. World Health Organization: Geneva, Switzerland, 2001; pp. 281-415.
2. EFSA, Opinion of the scientific panel on contaminations in the food chain on a request from the commission related to ochratoxin A in food. EFSA J. 2006, 365, 1-56.
3. Ringot, D.; Chango, A.; Schneider, Y.J.; Larondelle, Y. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem. Biol. Interact. 2006, 159, 18-46.
4. Pfohl-Leszkowicz, A.; Manderville, R.A. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 2007, 51, 61-99.
5. Al-Anati, L.; Petzinger, E. Immunotoxic activity of ochratoxin A. J. Vet. Pharmacol. Therap. 2006, 29, 79-90.
6. Álvarez, L.; Gil, A.G.; Ezpeleta, O.; Garcia-Jalon, J.A.; Lopez de Cerain, A. Immunotoxic effects of ochratoxin A in wistar rats after oral administration. Food Chem. Toxicol. 2004, 42, 825-834.
7. Al-Anati, L.; Katz, N.; Petzinger, E. Interference of arachidonic acid and its metabolites with TNF-α release by ochratoxin A from rat liver. Toxicology 2005, 208, 335-346.
8. Weidenbach, A.; Schuh, K.; Failing, K.; Petzinger, E. Ochratoxin A induced TNF-α release from the isolated and blood-free perfused rat liver. Mycotoxin Res. 2000, 16A, 189-193.
9. Al-Anati, L.; Reinehr, R.; Van Rooijen, N.; Petzinger, E. In vitro Induction of Tumor Necrosis Factor-α by Ochratoxin A from Rat Liver: Role of Kupffer cells. Mycotoxin Res. 2005, 21, 172-175.
10. Petzinger, E.; Weidenbach, A. Mycotoxins in the food chain: The role of ochratoxins. Livestock Prod. Sci. 2002, 76, 245-250.
11. Kopp, E.; Medzhitov, R. The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 1999, 11, 13-18.
12. Kopp, E.; Medzhitov, R. Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 2003, 15, 396-401.
13. Al-Anati, L.; Essid, E.; Reinehr, R.; Petzinger E. Silibinin protects OTA-mediated TNF-alpha release from perfused rat livers and isolated rat Kupffer cells. Mol. Nutr. Food Res. 2009, 53, 460-466.
14. Bhandari, N.; Brown, C.C.; Sharma, R.P. Fumonisin B1-induced localized activation of cytokine network in mouse liver. Food Chem. Toxicol. 2002, 40, 1483-1491.
15. He, Q.; Kim, J.; Sharma, R.P. Fumonisin B1 hepatotoxicity in mice is attenuated by depletion of Kupffer cells by gadolinium chloride. Toxicology 2005, 207, 137-147.
16. Cusumano, V.; Costa, G.B.; Trifiletti, R.; Merendino, R.A.; Mancuso, G. Functional impairment of rat Kupffer cells induced by aflatoxin B1 and its metabolites. FEMS Immunol. Med. Microbiol. 1995, 10, 151-155.
17. Arii, S.; Imamura, M. Physiological role of sinusoidal endothelial cells and Kupffer cells and their implication in the pathogenesis of liver injury. J. Hepatobiliary Pancreat Surg. 2000, 7, 40-48.
18. Neyrinck, A. Modulation of Kupffer cell activity: physio-pathological consequences on hepatic metabolism. Bull. Mem. Acad. R. Med. Belg. 2004, 159, 358-366.
19. Neyrinck, A.M.; Margagliotti, S.; Gomez, C.; Delzenne, N.M. Kupffer cell-derived prostaglandin E2 is involved in regulation of lipid synthesis in rat liver tissue. Cell Biochem. Funct. 2004, 22, 327-332.
20. Peters, T.; Karck. U.; Decker, K. Interdependence of tumor necrosis factor, prostaglandin E2, and protein synthesis in lipopolysaccharide-exposed rat Kupffer cells. Eur. J. Biochem. 1990, 191, 583-589.
21. Lazar, G.Jr.; Lazar, G.; Olah, J.; Husztik, E.; Duda, E. Effect of kupffer cell phagocytosis blockade indyced by gadolinium chloride and carrageenan on endotoxin sensitivity. Tissue localization of endotoxin and TNF production. J. Alloys Comp. 1995, 225, 623-625.
22. Diehl, A.M. Cytokine regulation of liver regeneration. In Normal and Malignant Liver Cell Growth; Fleig, W.E., Ed.; Kluwer Academic Publisher: Lancaster, UK, 1999; pp. 47-55.
23. Higuchi, H.; Kurose, I.; Watanabe, N.; Takaishi, M.; Ebinuma, H.; Saito, H.; Miura, S.; Ishii, H. Nitric oxide and tumor necrosis factor-α released from Kupffer cells synergistically mediate apoptosis of hepatoma cells: involvement of CD18/ ICAM-1-dependent NFkB activation process. In Cells of Hepatic Sinusoid; Knook, D.L., Wisse, E., Balabaud, C., Eds.; Kupffer Cell Foundation: Leiden, The Netherland, 1997, Volume 6, pp. 326-329.
24. Pagliara, P.; Carla, E.C.; Caforio, S.; Chionna, A.; Massa, S.; Abbro, L.; Dini. L. Kupffer cells promote lead nitrate-induced hepatocyte apoptosis via oxidative stress. Comp. Hepatol. 2003, 2, 8.
25. Atroshi, F.; Biese, I.; Saloniemi, H.; Ali-Vehmas, T.; Saari, S.; Rizzo, A.; Veijalainen, P. Significance of apoptosis and its relationship to antioxidants after ochratoxin A administration in mice. J. Pharm. Pharm. Sci. 2000, 3, 281-291.
26. Chopra M.; Link P.; Michels C.; Schrenk D. Characterization of ochratoxin A-induced apoptosis in primary rat hepatocytes. Cell Biol. Toxicol. 2009, DOI 10.1007/s10565-009-9131-0.
27. Heller, M.; Rosner, H.; Burkert, B.; Moller, U.; Hinsching, A.; Rohrmann, B.; Thierbach, S.; Kohler, H. In vitro studies into the influence of ochratoxin A on the production of tumor necrosis factor alpha by the human monocytic cell line THP-1. Dtsch Tierarztl Wochenschr. 2002, 109, 200-205.
28. Wang, H.C.; Zhang, H.; Zhou, T.L. Protective effect of hydrophilic Salvia monomer on liver ischemia/reperfusion injury induced by pro-inflammatory cytokines. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002, 22, 207-210.
29. Sakurai, F.; Terada, T.; Yasuda, K.; Yamashita, F.; Takakura, Y.; Hashida, M. The role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexes. Gene Ther. 2002, 9, 1120-1126.
30. Hayakawa, M.; Ishida, N.; Takeuchi, K.; Shibamoto, S.; Hori, T.; Oku, N.; Ito, F.; Tsujimoto, M. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biol. Chem. 1993, 268, 11290-11295.
31. Hayakawa, M.; Oku, N.; Takagi, T.; Hori, T.; Shibamoto, S.; Yamanaka, Y.; Takeuchi, K.; Tsujimoto, M.; and Ito, F. Involvement of prostaglandin-producing pathway in the cytotoxic action of tumor necrosis factor. Cell Struct. Funct. 1991, 16, 333-340.
32. Ferrante, M.C.; Raso, G.M.; Bilancione, M.; Esposito, E.; Iacono, A.; Meli, R. Differential modification of inflammatory enzymes in J774A.1 macrophages by ochratoxin A alone or in combination with lipopolysaccharide. Toxicol. Lett. 2008, 181, 40-46.
33. De Nardo, D.; De Nardo, C.M.; Nguyen, T.; Hamilton, J.A.; Scholz, G.M. Signaling crosstalk during sequential TLR4 and TLR9 activation amplifies the inflammatory response of mouse macrophages. J. Immunol. 2009, 183, 8110-8118.
34. Opal, S.M.; Huber, C.E. Bench-to-bedside review: Toll-like receptors and their role in septic shock. Crit. Care 2002, 6, 125-136.
35. Qureshi, S.T.; Lariviere, L.; Leveque, G.; Clermont, S.; Moore, K.J.; Gros, P.; Malo, D. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 1999, 189, 615-625.
36. Roach, J.C.; Glusman, G.; Rowen, L.; Kaur, A.; Purcell, M.K.; Smith, K.D.; Hood, L.E.; Aderem, A. The evolution of vertebrate Toll-like receptors. Proc. Natl. Acad. Sci. USA 2005, 102, 9577-9582.
37. Vogel, S.N.; Perera, P.Y.; Detore, G.R.; Bhat, N.; Carboni, J.M.; Haziot, A.; Goyert, S.M. CD14 dependent and independent signaling pathways in murine macrophages from normal or CD 14 knockout (CD14 KO) mice stimulated with LPS or taxol. Prog. Clin. Biol. Res. 1998, 397, 137-146.
38. Lentschat, A.; Karahashi, H.; Michelsen, K.S.; Thomas, L.S.; Zhang, W.; Vogel, S.N.; Arditi, M. Mastoparan, a G protein agonist peptide, differentially modulates TLR4- and TLR2-mediated signaling in human endothelial cells and murine macrophages. J. Immunol. 2005, 174, 4252-4261.
39. Janeway, C.A.; MedzhitovInnate J.R. Immune recognition. Annu. Rev. Immunol. 2002, 20, 197-216.
40. O'Neill, L.A.; Bowie, A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 2007, 7, 353-364.
41. Sauvant, C.; Holzinger, H.; Gekle, M. The nephrotoxin ochratoxin A induces key parameters of chronic interstitial nephropathy in renal proximal tubular cells. Cell Physiol. Biochem. 2005, 15, 125-134.
42. Sauvant, C.; Holzinger, H.; Gekle, M. Proximal tubular toxicity of ochratoxin A is amplified by simultaneous inhibition of the extracellular signal-regulated kinases 1/2. J. Pharmacol. Exp. Ther. 2005, 313, 234-241.
43. Kirkland, T.N.; Finley, F.; Leturcq, D.; Moriarty, A.; Lee, J.D.; Ulevitch, R.J. Tobias, P.S. Analysis of lipopolysaccharide binding by CD14. J. Biol. Chem. 1993, 268, 24818-24823.
44. Hailman, E.; Lichenstein, H.S.; Wurfel, M.M.; Miller, D.S.; Johnson, D.A.; Kelly, M.; Busse, L.A.; Zukowski, M.M.; Wright, S.D. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 1994, 179, 269-277.
45. Arditi, M.; Zhou, J.; Dorio, R.; Rong, G.W.; Goyert, S.M.; Kim, K.S. Endotoxin-mediated cell injury and activation: role of soluble CD14. Infect. Immun. 1993, 61, 3149-3156.
46. Arditi, M.; Zhou, J.; Torres, M.; Durden, D.L.; Stins, M.; Kim, K.S. Lipopolysaccharide stimulates the tyrosine phosphorylation of mitogen-activated protein kinases p44, p42, and p41 in vascular endothelial cells in a soluble CD14-dependent manner. J. Immunol. 1995, 155, 3994-4003.
47. Haziot, A.; Rong, G.W.; Silver, J.; Goyert S.M. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 1993, 151, 1500-1507.
48. Eyhorn, S.; Schlayer, H.J.; Henninger, H.P.; Dieter, P.; Hermann, R.; Woort-Menker, M.; Becker, H.; Schaefer, H.E.; Decker, K. Rat hepatic siniusiodal endothelial cells in monolayer culture. Biochemical and ultrastructural characteristics. J. Hepatol. 1988, 6, 23-35.
49. Petzinger, E.; Müller, N.; Föllmann, W.; Deutscher, J.; Kinne, R.K. Uptake of bumetanide into isolated rat hepatocytes and primary liver cell cultures. Am. J. Physiol. 1989, 256, G78-G86.
50. Renz, H.; Gong, J.H.; Schmidt, A.; Nain, M.; Gemsa, D. Release of tumor necrosis factors-α from macrophages enhancement and suppression are dose-dependantly regulated by prostaglandin E2 and cyclic nucleotides. J. Immunol. 1988, 141, 2388-2393.